{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T22:13:31Z","timestamp":1795040011703,"version":"4.10.2"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007508","name":"Stiftelsen Sigurd and Elsa Goljes Minne","doi-asserted-by":"publisher","award":["LA2024-0126"],"award-info":[{"award-number":["LA2024-0126"]}],"id":[{"id":"10.13039\/501100007508","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2021-03324"],"award-info":[{"award-number":["2021-03324"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-01030"],"award-info":[{"award-number":["2020-01030"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2024-00721"],"award-info":[{"award-number":["2024-00721"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010815","name":"Stiftelsen f\u00f6r Gamla Tj\u00e4narinnor","doi-asserted-by":"publisher","award":["2021-01235"],"award-info":[{"award-number":["2021-01235"]}],"id":[{"id":"10.13039\/100010815","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Blood biomarkers of Alzheimer\u2019s disease (AD) are promising for dementia prediction, but their association with progression across intermediate stages of cognitive decline in the general population remains unclear. We followed 2148 dementia-free individuals from a Swedish population-based cohort for up to 16 years. Associations between baseline AD blood biomarkers and transitions between normal cognition, mild cognitive impairment (MCI), and dementia were examined. Lower amyloid-\u03b242\/40 ratio and higher phosphorylated-tau181 (p-tau181), p-tau217, total-tau, neurofilament light chain (NfL), and glial fibrillary acidic protein (GFAP) were associated with faster progression from MCI to all-cause and AD dementia, with the strongest associations for NfL and p-tau217. Elevated NfL and GFAP were linked to reduced MCI reversion to normal cognition, whereas no biomarker was associated with MCI development from normal cognition. These findings show robust group-level associations and indicate that AD blood biomarkers may help stratify dementia risk at the MCI stage in the community.<\/jats:p>","DOI":"10.1038\/s41467-025-66728-2","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T04:12:39Z","timestamp":1763871159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Blood biomarkers of Alzheimer\u2019s disease and progression across different stages of cognitive decline in the community"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0139-8287","authenticated-orcid":false,"given":"Martina","family":"Valletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-4830","authenticated-orcid":false,"given":"Davide Liborio","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8163-1634","authenticated-orcid":false,"given":"Caterina","family":"Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Rizzuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0011-1179","authenticated-orcid":false,"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canevelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-7744","authenticated-orcid":false,"given":"Matilda","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7674-2014","authenticated-orcid":false,"given":"Claudia","family":"Fredolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika J.","family":"Laukka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fratiglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6312-3815","authenticated-orcid":false,"given":"Giulia","family":"Grande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"key":"66728_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23746-0","volume":"12","author":"NC Cullen","year":"2021","unstructured":"Cullen, N. C. et al. Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat. Commun. 12, 3555 (2021).","journal-title":"Nat. Commun."},{"key":"66728_CR2","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","volume":"27","author":"S Palmqvist","year":"2021","unstructured":"Palmqvist, S. et al. Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med. 27, 1034\u20131042 (2021).","journal-title":"Nat. Med."},{"key":"66728_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41582-018-0079-7","volume":"14","author":"H Hampel","year":"2018","unstructured":"Hampel, H. et al. Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic. Nat. Rev. Neurol. 14, 639\u2013652 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"66728_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 21, 66\u201377 (2022).","journal-title":"Lancet Neurol."},{"key":"66728_CR5","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1001\/jama.2024.6619","volume":"332","author":"Y Lu","year":"2024","unstructured":"Lu, Y. et al. Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia. JAMA 332, 1258 (2024).","journal-title":"JAMA"},{"key":"66728_CR6","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awaa054","volume":"143","author":"F de Wolf","year":"2020","unstructured":"de Wolf, F. et al. Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study. Brain J. Neurol. 143, 1220\u20131232 (2020).","journal-title":"Brain J. Neurol."},{"key":"66728_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/alz.12614","volume":"19","author":"H Stocker","year":"2023","unstructured":"Stocker, H. et al. Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer\u2019s disease risk: Results from a prospective cohort followed over 17 years. Alzheimers Dement. J. Alzheimers Assoc. 19, 25\u201335 (2023).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR8","doi-asserted-by":"publisher","unstructured":"Cronj\u00e9, H. T. et al. Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study. Alzheimers Dement. J. Alzheimers Assoc. https:\/\/doi.org\/10.1002\/alz.13367. (2023).","DOI":"10.1002\/alz.13367"},{"key":"66728_CR9","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1038\/s41591-025-03605-x","volume":"31","author":"G Grande","year":"2025","unstructured":"Grande, G. et al. Blood-based biomarkers of Alzheimer\u2019s disease and incident dementia in the community. Nat. Med. 31, 2027\u20132035 (2025).","journal-title":"Nat. Med."},{"key":"66728_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/alz.12002","volume":"16","author":"G Grande","year":"2020","unstructured":"Grande, G. et al. Cognitive and physical markers of prodromal dementia: A 12-year-long population study. Alzheimers Dement. J. Alzheimers Assoc. 16, 153\u2013161 (2020).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR11","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt, L. et al. Duration of preclinical, prodromal and dementia alzheimer disease stages in relation to age, sex, and APOE genotype. Alzheimers Dement. J. Alzheimers Assoc. 15, 888\u2013898 (2019).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR12","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","volume":"29","author":"WK Self","year":"2023","unstructured":"Self, W. K. & Holtzman, D. M. Emerging diagnostics and therapeutics for Alzheimer disease. Nat. Med. 29, 2187\u20132199 (2023).","journal-title":"Nat. Med."},{"key":"66728_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s43587-020-00003-5","volume":"1","author":"NC Cullen","year":"2021","unstructured":"Cullen, N. C. et al. Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations. Nat. Aging 1, 114\u2013123 (2021).","journal-title":"Nat. Aging"},{"key":"66728_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-022-00990-0","volume":"14","author":"A Pichet Binette","year":"2022","unstructured":"Pichet Binette, A. et al. Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer\u2019s dementia in mild cognitive impairment patients. Alzheimers Res. Ther. 14, 46 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"66728_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13195-022-01005-8","volume":"14","author":"C Groot","year":"2022","unstructured":"Groot, C. et al. Diagnostic and prognostic performance to detect Alzheimer\u2019s disease and clinical progression of a novel assay for plasma p-tau217. Alzheimers Res. Ther. 14, 67 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"66728_CR16","doi-asserted-by":"publisher","unstructured":"Oeckl, P. et al. Serum GFAP differentiates Alzheimer\u2019s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J. Neurol. Neurosurg. Psychiatry jnnp-2021-328547 https:\/\/doi.org\/10.1136\/jnnp-2021-328547. (2022).","DOI":"10.1136\/jnnp-2021-328547"},{"key":"66728_CR17","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1136\/jnnp-2024-333467","volume":"95","author":"S Lehmann","year":"2024","unstructured":"Lehmann, S. et al. Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairment. J. Neurol. Neurosurg. Psychiatry 95, 1046\u20131053 (2024).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"66728_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.jalz.2018.03.005","volume":"14","author":"R Brookmeyer","year":"2018","unstructured":"Brookmeyer, R. & Abdalla, N. Estimation of lifetime risks of Alzheimer\u2019s disease dementia using biomarkers for preclinical disease. Alzheimers Dement. J. Alzheimers Assoc. 14, 981\u2013988 (2018).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR19","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41582-024-01004-3","volume":"20","author":"N Villain","year":"2024","unstructured":"Villain, N. & Planche, V. Disentangling clinical and biological trajectories of neurodegenerative diseases. Nat. Rev. Neurol. 20, 693\u2013694 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"66728_CR20","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack, C. R. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. J. Alzheimers Assoc. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois, B. et al. Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation. JAMA Neurol. 81, 1304\u20131311 (2024).","journal-title":"JAMA Neurol."},{"key":"66728_CR22","doi-asserted-by":"publisher","unstructured":"Bouteloup, V. et al. Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers. JAMA Neurol. https:\/\/doi.org\/10.1001\/jamaneurol.2025.0142. (2025).","DOI":"10.1001\/jamaneurol.2025.0142"},{"key":"66728_CR23","doi-asserted-by":"publisher","first-page":"1069411","DOI":"10.3389\/fneur.2023.1069411","volume":"14","author":"P Kivis\u00e4kk","year":"2023","unstructured":"Kivis\u00e4kk, P. et al. Plasma biomarkers for diagnosis of Alzheimer\u2019s disease and prediction of cognitive decline in individuals with mild cognitive impairment. Front. Neurol. 14, 1069411 (2023).","journal-title":"Front. Neurol."},{"key":"66728_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1111\/ene.15762","volume":"30","author":"A Silva-Sp\u00ednola","year":"2023","unstructured":"Silva-Sp\u00ednola, A. et al. Blood biomarkers in mild cognitive impairment patients: Relationship between analytes and progression to Alzheimer disease dementia. Eur. J. Neurol. 30, 1565\u20131573 (2023).","journal-title":"Eur. J. Neurol."},{"key":"66728_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jamda.2016.06.020","volume":"17","author":"M Canevelli","year":"2016","unstructured":"Canevelli, M. et al. Spontaneous reversion of mild cognitive impairment to normal cognition: a systematic review of literature and meta-analysis. J. Am. Med. Dir. Assoc. 17, 943\u2013948 (2016).","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"66728_CR26","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/WAD.0000000000000145","volume":"30","author":"M Malek-Ahmadi","year":"2016","unstructured":"Malek-Ahmadi, M. Reversion From mild cognitive impairment to normal cognition: a meta-analysis. Alzheimer Dis. Assoc. Disord. 30, 324\u2013330 (2016).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"66728_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/dad2.70074","volume":"17","author":"S Salemme","year":"2025","unstructured":"Salemme, S. et al. The prognosis of mild cognitive impairment: a systematic review and meta-analysis. Alzheimers Dement. Amst. Neth. 17, e70074 (2025).","journal-title":"Alzheimers Dement. Amst. Neth."},{"key":"66728_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","volume":"5","author":"AE Roher","year":"2009","unstructured":"Roher, A. E. et al. A\u03b2 peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease. Alzheimers Dement. J. Alzheimers Assoc. 5, 18\u201329 (2009).","journal-title":"Alzheimers Dement. J. Alzheimers Assoc."},{"key":"66728_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","volume":"16","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg, H. & Blennow, K. Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics. Mol. Neurodegener. 16, 10 (2021).","journal-title":"Mol. Neurodegener."},{"key":"66728_CR30","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1212\/WNL.0000000000003246","volume":"87","author":"N Mattsson","year":"2016","unstructured":"Mattsson, N. et al. Plasma tau in Alzheimer disease. Neurology 87, 1827\u20131835 (2016).","journal-title":"Neurology"},{"key":"66728_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders. JAMA 324, 772 (2020).","journal-title":"JAMA"},{"key":"66728_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"66728_CR33","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze, S. et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer\u2019s disease. Brain J. Neurol. 146, 1592\u20131601 (2023).","journal-title":"Brain J. Neurol."},{"key":"66728_CR34","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/S1474-4422(25)00227-3","volume":"24","author":"J Therriault","year":"2025","unstructured":"Therriault, J. et al. Blood phosphorylated tau for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 24, 740\u2013752 (2025).","journal-title":"Lancet Neurol."},{"key":"66728_CR35","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1001\/jamaneurol.2019.1534","volume":"76","author":"C Bridel","year":"2019","unstructured":"Bridel, C. et al. Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: a systematic review and meta-analysis. JAMA Neurol. 76, 1035\u20131048 (2019).","journal-title":"JAMA Neurol."},{"key":"66728_CR36","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","volume":"14","author":"M Khalil","year":"2018","unstructured":"Khalil, M. et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 14, 577\u2013589 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"66728_CR37","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","volume":"357","author":"Neuropathology Group","year":"2001","unstructured":"Neuropathology Group Medical Research Council Cognitive Function and Aging Study. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Lancet Lond. Engl. 357, 169\u2013175 (2001).","journal-title":"Lancet Lond. Engl."},{"key":"66728_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/0891988705281872","volume":"18","author":"L White","year":"2005","unstructured":"White, L. et al. Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J. Geriatr. Psychiatry Neurol. 18, 224\u2013227 (2005).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"66728_CR39","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","volume":"69","author":"JA Schneider","year":"2007","unstructured":"Schneider, J. A., Arvanitakis, Z., Bang, W. & Bennett, D. A. Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology 69, 2197\u20132204 (2007).","journal-title":"Neurology"},{"key":"66728_CR40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider, J. A., Arvanitakis, Z., Leurgans, S. E. & Bennett, D. A. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann. Neurol. 66, 200\u2013208 (2009).","journal-title":"Ann. Neurol."},{"key":"66728_CR41","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper, B. & Karran, E. The cellular phase of Alzheimer\u2019s disease. Cell 164, 603\u2013615 (2016).","journal-title":"Cell"},{"key":"66728_CR42","doi-asserted-by":"publisher","unstructured":"Valletta, M. et al. Blood biomarkers of Alzheimer\u2019s disease in the community: Variation by chronic diseases and inflammatory status. Alzheimers Dement. J. Alzheimers Assoc. https:\/\/doi.org\/10.1002\/alz.13860. (2024).","DOI":"10.1002\/alz.13860"},{"key":"66728_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6","volume":"11","author":"M Khalil","year":"2020","unstructured":"Khalil, M. et al. Serum neurofilament light levels in normal aging and their association with morphologic brain changes. Nat. Commun. 11, 812 (2020).","journal-title":"Nat. Commun."},{"key":"66728_CR44","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13195-022-01011-w","volume":"14","author":"PR Kac","year":"2022","unstructured":"Kac, P. R. et al. Diagnostic value of serum versus plasma phospho-tau for Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 65 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"66728_CR45","doi-asserted-by":"publisher","first-page":"105644","DOI":"10.1016\/j.msard.2024.105644","volume":"87","author":"K Koerbel","year":"2024","unstructured":"Koerbel, K. et al. Evaluating the utility of serum NfL, GFAP, UCHL1 and tTAU as estimates of CSF levels and diagnostic instrument in neuroinflammation and multiple sclerosis. Mult. Scler. Relat. Disord. 87, 105644 (2024).","journal-title":"Mult. Scler. Relat. Disord."},{"key":"66728_CR46","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.70114","volume":"169","author":"Y Chen","year":"2025","unstructured":"Chen, Y. et al. Equivalence of plasma and serum for clinical measurement of p-tau217: comparative analyses of four blood-based assays. J. Neurochem. 169, e70114 (2025).","journal-title":"J. Neurochem."},{"key":"66728_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/BF03324546","volume":"16","author":"M Lagergren","year":"2004","unstructured":"Lagergren, M. et al. A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC). Aging Clin. Exp. Res. 16, 158\u2013168 (2004).","journal-title":"Aging Clin. Exp. Res."},{"key":"66728_CR48","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm, E. et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet Lond. Engl. 370, 1453\u20131457 (2007).","journal-title":"Lancet Lond. Engl."},{"key":"66728_CR49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1017\/S0033291713001736","volume":"44","author":"A Pantzar","year":"2014","unstructured":"Pantzar, A. et al. Cognitive deficits in unipolar old-age depression: a population-based study. Psychol. Med. 44, 937\u2013947 (2014).","journal-title":"Psychol. Med."},{"key":"66728_CR50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/ageing\/afaa228","volume":"50","author":"RA Dunne","year":"2020","unstructured":"Dunne, R. A. et al. Mild Cognitive Impairment: the Manchester consensus. Age Ageing 50, 72\u201380 (2020).","journal-title":"Age Ageing"},{"key":"66728_CR51","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1176\/ajp.152.8.1228","volume":"152","author":"SB Guze","year":"1995","unstructured":"Guze, S. B. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Am. J. Psychiatry 152, 1228\u20131228 (1995).","journal-title":"Am. J. Psychiatry"},{"key":"66728_CR52","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"66728_CR53","first-page":"1417","volume":"72","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2017","unstructured":"Calder\u00f3n-Larra\u00f1aga, A. et al. Assessing and measuring chronic multimorbidity in the older population: a proposal for its operationalization. J. Gerontol. A: Biol. Sci. Med. Sci. 72, 1417\u20131423 (2017).","journal-title":"J. Gerontol. A: Biol. Sci. Med. Sci."},{"key":"66728_CR54","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/biom.12899","volume":"74","author":"C Jackson","year":"2018","unstructured":"Jackson, C. Ardo Van Den Hout. Multi-state survival models for interval-censored data. Boca Raton: CRC Press. Biometrics 74, 773\u2013773 (2018).","journal-title":"Biometrics"},{"key":"66728_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cmpb.2019.06.004","volume":"178","author":"A van den Hout","year":"2019","unstructured":"van den Hout, A., Sum Chan, M. & Matthews, F. Estimation of life expectancies using continuous-time multi-state models. Comput. Methods Prog. Biomed. 178, 11\u201318 (2019).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"66728_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i08","volume":"38","author":"C Jackson","year":"2011","unstructured":"Jackson, C. Multi-state models for panel data: the msm package for R. J. Stat. Softw. 38, 1\u201328 (2011).","journal-title":"J. Stat. Softw."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66728-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66728-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66728-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:01:51Z","timestamp":1764385311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-66728-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["66728"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-66728-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"1 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10412"}}